BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11585763)

  • 1. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.
    Chakraborty M; Qiu SG; Vasudevan KM; Rangnekar VM
    Cancer Res; 2001 Oct; 61(19):7255-63. PubMed ID: 11585763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL.
    Mora AL; Corn RA; Stanic AK; Goenka S; Aronica M; Stanley S; Ballard DW; Joyce S; Boothby M
    Cell Death Differ; 2003 Sep; 10(9):1032-44. PubMed ID: 12934078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells.
    Bertram J; Peacock JW; Tan C; Mui AL; Chung SW; Gleave ME; Dedhar S; Cox ME; Ong CJ
    Cancer Res; 2006 May; 66(9):4781-8. PubMed ID: 16651432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
    Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
    Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression activity of pro-apoptotic gene products in cancer cells, a potential application for cancer gene therapy.
    Lin J; Page C; Jin X; Sethi AO; Patel R; Nunez G
    Anticancer Res; 2001; 21(2A):831-9. PubMed ID: 11396172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in prostate cancer: progressive and therapeutic implications (Review).
    Wang G; Reed E; Li QQ
    Int J Mol Med; 2004 Jul; 14(1):23-34. PubMed ID: 15202013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3.
    Chendil D; Das A; Dey S; Mohiuddin M; Ahmed MM
    Cancer Biol Ther; 2002; 1(2):152-60. PubMed ID: 12170775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
    Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review).
    Gupta S
    Int J Oncol; 2003 Jan; 22(1):15-20. PubMed ID: 12469180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis.
    Hyer ML; Voelkel-Johnson C; Rubinchik S; Dong J; Norris JS
    Mol Ther; 2000 Oct; 2(4):348-58. PubMed ID: 11020350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis.
    Bergmann M; Kukoc-Zivojnov N; Chow KU; Trepohl B; Hoelzer D; Weidmann E; Mitrou PS; Boehrer S
    Ann Hematol; 2004 Oct; 83(10):646-53. PubMed ID: 15316756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
    Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB; Memon SA; Zacharchuk CM
    J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.
    Srinivasan S; Ranga RS; Burikhanov R; Han SS; Chendil D
    Cancer Res; 2007 Jan; 67(1):246-53. PubMed ID: 17185378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.
    Brás A; Albar JP; Leonardo E; de Buitrago GG; Martínez-A C
    Cell Death Differ; 2000 Mar; 7(3):262-71. PubMed ID: 10745271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53.
    Herrmann JL; Briones F; Brisbay S; Logothetis CJ; McDonnell TJ
    Oncogene; 1998 Dec; 17(22):2889-99. PubMed ID: 9879995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
    Afford SC; Ahmed-Choudhury J; Randhawa S; Russell C; Youster J; Crosby HA; Eliopoulos A; Hubscher SG; Young LS; Adams DH
    FASEB J; 2001 Nov; 15(13):2345-54. PubMed ID: 11689460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model.
    Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H
    Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.